Cargando…
Classification of the spliceogenic BRCA1 c.4096+3A>G variant as likely benign based on cosegregation data and identification of a healthy homozygous carrier
BRCA1, c.4096+3A>G was identified in a consanguineous Danish family with several cases of breast/ovarian cancer. In silico analysis and splicing assays indicated that the variant caused aberrant splicing. However, based on segregation data and the finding of a healthy homozygous carrier, we class...
Autores principales: | Byrjalsen, Anna, Steffensen, Ane Y., Hansen, Thomas v. O., Wadt, Karin, Gerdes, Anne‐Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458035/ https://www.ncbi.nlm.nih.gov/pubmed/28588830 http://dx.doi.org/10.1002/ccr3.944 |
Ejemplares similares
-
Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays
por: Fraile-Bethencourt, Eugenia, et al.
Publicado: (2018) -
Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18
por: Fraile-Bethencourt, Eugenia, et al.
Publicado: (2017) -
The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
por: Arason, Adalgeir, et al.
Publicado: (2019) -
Minigene Splicing Assays Identify 12 Spliceogenic Variants of BRCA2 Exons 14 and 15
por: Fraile-Bethencourt, Eugenia, et al.
Publicado: (2019) -
The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
por: Colombo, Mara, et al.
Publicado: (2018)